AAAAAA

   
Results: 1-25 | 26-47
Results: 1-25/47

Authors: AMIOT L LANGANAY T DRENOU B LELONG B LEPRISE PY LOGEAIS Y COLIMON R FAUCHET R
Citation: L. Amiot et al., SPONTANEOUS-RECOVERY FROM SEVERE PARVOVIRUS B19 PURE RED-CELL APLASIA, IN A HEART-TRANSPLANT RECIPIENT, AS DEMONSTRATED BY MARROW CULTURE, HEM CELL TH, 40(2), 1998, pp. 71-73

Authors: DRENOU B AMIOT L LAMY T LEPRISE PY FAUCHET R
Citation: B. Drenou et al., MULTIDRUG-RESISTANCE IN AGGRESSIVE LYMPHOPROLIFERATIVE DISORDERS OF TAND NATURAL-KILLER ORIGIN, Leukemia & lymphoma, 30(3-4), 1998, pp. 381-387

Authors: ANDRIEU JM JAIS JP COLONNA P DESABLENS B BRIERE J FRANCOIS S HAROUSSEAU JL CASASSUS P LEMEVEL A LEPRISE PY GHANDOUR C GUILHOT F LEJEUNE F
Citation: Jm. Andrieu et al., 10-YEAR RESULTS OF A STRATEGY COMBINING 3 CYCLES OF ABVD AND HIGH-DOSE EXTENDED IRRADIATION FOR TREATING HODGKINS-DISEASE AT ADVANCED STAGES, Annals of oncology, 9(2), 1998, pp. 195-203

Authors: HAROUSSEAU JL WITZ F LIOURE B LEPRISE PY SOLARY E ABGRALL JF CASSASUS P AUDHUY B TRAVADE P CAHN JY
Citation: Jl. Harousseau et al., G-CSF AFTER INTENSIVE CONSOLIDATION CHEMOTHERAPY (ICC) IN ACUTE MYELOID-LEUKEMIA (AML), British Journal of Haematology, 102(1), 1998, pp. 86-86

Authors: AMIOT L ONNO M LAMY T DAURIAC C LEPRISE PY FAUCHET R DRENOU B
Citation: L. Amiot et al., LOSS OF HLA MOLECULES IN B-LYMPHOMAS IS ASSOCIATED WITH AN AGGRESSIVECLINICAL COURSE, British Journal of Haematology, 100(4), 1998, pp. 655-663

Authors: LAMY T DRENOU B FARDEL O AMIOT L GRULOIS I LEPRISE PY LOUGHRAN TP FAUCHET R
Citation: T. Lamy et al., MULTIDRUG-RESISTANCE ANALYSIS IN LYMPHOPROLIFERATIVE DISEASE OF LARGEGRANULAR LYMPHOCYTES, British Journal of Haematology, 100(3), 1998, pp. 509-515

Authors: WITZ F SADOUN A PERRIN MC BERTHOU C BRIERE J CAHN JY LIOURE B WITZ B FRANCOIS S DESABLENS B PIGNON B LEPRISE PY AUDHUY B CAILLOT D CASASSUS P DELAIN M CHRISTIAN B TELLIER Z POLIN V HURTELOUP P HAROUSSEAU JL
Citation: F. Witz et al., A PLACEBO-CONTROLLED STUDY OF RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR ADMINISTERED DURING AND AFTER INDUCTION TREATMENT FOR DE-NOVO ACUTE MYELOGENOUS LEUKEMIA IN ELDERLY PATIENTS, Blood, 91(8), 1998, pp. 2722-2730

Authors: MAUGENDRE D DERRIEN C GRULOIS I SIMON JP GUILHEM I POIRIER JY LEPRISE PY ALLANNIC H
Citation: D. Maugendre et al., PRIMARY ADRENAL LYMPHOMA WITH LATENT ADRE NAL INSUFFICIENCY - A CASE-REPORT AND REVIEW OF THE LITERATURE, Annales d'Endocrinologie, 59(1), 1998, pp. 34-39

Authors: YILMAZ U JAIS JP DESABLENS B MOREAU P BRIERE J GARDEMBAS M LEMEVEL A CASASSUS P LEPRISE PY DELWAIL V ANDRIEU JM
Citation: U. Yilmaz et al., COMBINED-MODALITY TREATMENT AND ADJUVANT LUMBO-SPLENIC RADIOTHERAPY (RT) IN SUPRA-DIAPHRAGMATIC (SD) CLINICAL STAGE (CS) I-II HODGKIN-DISEASE (HD) RESULTS IN DECREASED RATES OF INFRA-DIAPHRAGMATIC (ID) NODAL RELAPSES(R), European journal of cancer, 33, 1997, pp. 1226-1226

Authors: LANSON B DRENOU B GUERET P AMIOT L BERNARD M DAURIAC C LEPRISE PY FAUCHET R
Citation: B. Lanson et al., PROGNOSTIC VALUE OF CD71 EXPRESSION IN MANTLE CELL LYMPHOMA, Experimental hematology, 25(8), 1997, pp. 401-401

Authors: LAMY I CORLU A FARDEL O GANDEMER V RIALLAND M LEBERRE C LEPRISE PY FAUCHET R COULOMBEL L GUGUENGUILLOUZO C
Citation: I. Lamy et al., RAT-LIVER BILIARY EPITHELIAL-CELLS SUPPORT LONG-TERM PRODUCTION OF HEMATOPOIETIC PROGENITORS FROM HUMAN CD34(+) CELLS, British Journal of Haematology, 98(3), 1997, pp. 560-568

Authors: HAROUSSEAU JL WITZ F DESABLENS B LEPRISE PY FRANCOIS S DELAIN M ABGRALL JF SOLARY E
Citation: Jl. Harousseau et al., G-CSF AFTER INTENSIVE CONSOLIDATION CHEMOTHERAPY IN ACUTE MYELOID-LEUKEMIA (AML), Blood, 90(10), 1997, pp. 2249-2249

Authors: DESABLENS B FRANCOIS S RODIER JM LEMEVEL A DELWAIL V SENSEBE L LEPRISE PY COLOMBAT P DECONINCK E BRIERE J HAROUSSEAU JL BAUDUER F LAMOUR C
Citation: B. Desablens et al., PROGNOSTIC FACTORS IN HIV-NEGATIVE PRIMARY CNS NHL - ANALYSIS FROM 135 PATIENTS TREATED BY THE LCP-88 TRIAL, Blood, 90(10), 1997, pp. 2609-2609

Authors: DRENOU B LAMY T AMIOT L FARDEL O CAULETMAUGENDRE S SASPORTES M DIEBOLD J LEPRISE PY FAUCHET R
Citation: B. Drenou et al., CD3(-)CD56(-HODGKINS-LYMPHOMAS WITH AN AGGRESSIVE-BEHAVIOR RELATED TOMULTIDRUG-RESISTANCE() NON), Blood, 89(8), 1997, pp. 2966-2974

Authors: LAMY T DEVILLERS A BERNARD M MOISAN A GRULOIS I DRENOU B AMIOT L FAUCHET R LEPRISE PY
Citation: T. Lamy et al., INAPPARENT POLYCYTHEMIA-VERA - AN UNRECOGNIZED DIAGNOSIS, The American journal of medicine, 102(1), 1997, pp. 14-20

Authors: GOASGUEN JE LAMY T BERGERON C SUNARAM BLY MORDELET E GORRE G DOSSOT JM LEGALL E GROSBOIS B LEPRISE PY FAUCHET R
Citation: Je. Goasguen et al., MULTIFACTORIAL DRUG-RESISTANCE PHENOMENON IN ACUTE LEUKEMIAS - IMPACTOF P170-MDR1, LRP56 PROTEIN, GLUTATHIONE-TRANSFERASES AND METALLOTHIONEIN SYSTEMS ON CLINICAL OUTCOME, Leukemia & lymphoma, 23(5-6), 1996, pp. 567-576

Authors: FARDEL O COURTOIS A DRENOU B LAMY T LECUREUR V LEPRISE PY FAUCHET R
Citation: O. Fardel et al., INHIBITION OF P-GLYCOPROTEIN ACTIVITY IN HUMAN LEUKEMIC-CELLS BY MIFEPRISTONE, Anti-cancer drugs, 7(6), 1996, pp. 671-677

Authors: PIGNON B WITZ F DESABLENS B LEPRISE PY FRANCOIS S LINASSIER C BERTHOU C CAILLOT D LIOURE B CAHN JY CASASSUS P SADOUN A AUDHUY B GUYOTAT D BRIERE J VILQUE JP BARANGER L POLIN V BERTHAUD P HURTELOUP P HERVE P HAROUSSEAU JL
Citation: B. Pignon et al., TREATMENT OF ACUTE MYELOGENOUS LEUKEMIA IN PATIENTS AGED 50-65 - IDARUBICIN IS MORE EFFECTIVE THAN ZORUBICIN FOR REMISSION INDUCTION AND PROLONGED DISEASE-FREE SURVIVAL CAN BE OBTAINED USING A UNIQUE CONSOLIDATION COURSE, British Journal of Haematology, 94(2), 1996, pp. 333-341

Authors: GOASGUEN JE LAMY T BERGERON C SUNNARAM BL MORDELET E GORRE G DOSSOT JM LEGALL E GROSBOIS B LEPRISE PY FAUCHET R
Citation: Je. Goasguen et al., ROLE OF METALLOTHIONEIN IN THE ACUTE LEUKEMIAS RESISTANCE PROCESS, Blood, 88(10), 1996, pp. 3319-3319

Authors: KILADJIAN JJ GARDIN C GUILMIN F AMAR M LEPRISE PY DESABLENS B ABGRALL JF BRIERE J
Citation: Jj. Kiladjian et al., HYDROXYUREA-RELATED ACUTE-LEUKEMIA IN ESSENTIAL THROMBOCYTHEMIA (ET) - LONG-TERM RESULTS OF A PROSPECTIVE-STUDY, Blood, 88(10), 1996, pp. 3552-3552

Authors: DESABLENS B GARDEMBAS M LEMEVEL A SENSEBE L HAIEMEDER C COLOMBAT P LEPRISE PY DELWAIL V CAHN JY BRIERE J DUTEL JL MAISONNEUVE H HAROUSSEAU JL CASASSUS P GARIDI R
Citation: B. Desablens et al., 7-YEAR RESULTS OF 104 HIV-NEGATIVE PRIMARY CNS LYMPHOMAS TREATED BY THE POF LCP 88 TRIAL, Blood, 88(10), 1996, pp. 2257-2257

Authors: COLONNA P DELWAIL V DESABLENS B GARDEMBAS M SENSEBE L HAROUSSEAU JL GARDIN C CASSUS P SIMON M LEPRISE PY GHANDOUR C FRILAY Y LEMEVEL A ANDRIEU JM
Citation: P. Colonna et al., HODGKINS-DISEASE (HD), CLINICAL STAGES (CS) IA-IIIB WITHOUT BULKY TUMOR - INTERIM RESULTS OF THE GOELMAS RANDOMIZED H90-NM PROTOCOL, European journal of cancer, 31A, 1995, pp. 768-768

Authors: COLONNA P DELWAIL V DESABLENS B FRANCOIS S SENSEBE L TURLURE P CASASSUS P SIMON M LEPRISE PY GHANDOUR C FAIN O LEMEVEL A ANDRIEU JM
Citation: P. Colonna et al., BULKY HODGKINS-DISEASE (HD) - INTERIM RESULTS OF THE GOELAMS RANDOMIZED H90-M PROTOCOL, European journal of cancer, 31A, 1995, pp. 779-779

Authors: PLESSIS P LAMY T DONNIO PY AUTULY F GRULOIS I LEPRISE PY AVRIL JL
Citation: P. Plessis et al., EPIDEMIOLOGIC ANALYSIS OF GLYCOPEPTIDE-RESISTANT ENTEROCOCCUS STRAINSIN NEUTROPENIC PATIENTS RECEIVING PROLONGED VANCOMYCIN ADMINISTRATION, European journal of clinical microbiology & infectious diseases, 14(11), 1995, pp. 959-963

Authors: LAMY T DRENOU B GRULOIS I FARDEL O JACQUELINET C GOASGUEN J DAURIAC C AMIOT L BERNARD M FAUCHET R LEPRISE PY
Citation: T. Lamy et al., MULTIDRUG-RESISTANCE (MDR) ACTIVITY IN ACUTE-LEUKEMIA DETERMINED BY RHODAMINE-123 EFFLUX ASSAY, Leukemia, 9(9), 1995, pp. 1549-1555
Risultati: 1-25 | 26-47